Thalidomide toxicity in patients with AL (primary) amyloidosis.

被引：0
|
作者：
Palladini, G [1 ]
Perfetti, V [1 ]
Obici, L [1 ]
Merlini, G [1 ]
机构：
[1] Univ Pavia, Univ Hosp IRCCS Policlin San Matteo, Biotechnol Res Labs, Dept Biochem, I-27100 Pavia, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1543
引用
收藏
页码：397A / 397A
页数：1
相关论文
共 50 条
  • [1] Thalidomide is an effective agent for patients with primary amyloidosis.
    Vescio, RA
    Berenson, JR
    BLOOD, 2000, 96 (11) : 296B - 296B
  • [2] A phase I/II trial of thalidomide for patients with AL amyloidosis.
    Seldin, DC
    Choufani, E
    Skinner, M
    Wright, DG
    Dember, L
    Weisman, J
    Fennessey, S
    Finn, K
    Sanchorawala, V
    BLOOD, 2001, 98 (11) : 164A - 164A
  • [3] High doses of thalidomide are not well tolerated in patients with primary systemic amyloidosis.
    Dispenzieri, A
    Lacy, MQ
    Rajkumar, SV
    Geyer, SM
    Fonseca, R
    Witzig, TE
    Lust, JA
    Greipp, PR
    Kyle, RA
    Gertz, MA
    BLOOD, 2002, 100 (11) : 398A - 398A
  • [4] Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.
    Lachmann, HJ
    Booth, DR
    Booth, SE
    Bybee, A
    Gilbertson, JA
    Gillmore, JD
    Pepys, MB
    Hawkins, PN
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1786 - 1791
  • [5] Efficacy of risk adapted cyclophosphamide, thalidomide and dexamethasone in systemic AL amyloidosis.
    Wechalekar, AD
    Goodman, HJB
    Gillmore, JD
    Lachmann, HJ
    Offer, M
    Bradwell, AR
    Hawkins, PN
    BLOOD, 2005, 106 (11) : 976A - 976A
  • [6] Primary systemic amyloidosis.
    Comenzo R.L.
    Current Treatment Options in Oncology, 2000, 1 (1) : 83 - 89
  • [7] Primary systemic amyloidosis.
    Gertz M.A.
    Rajkumar S.V.
    Current Treatment Options in Oncology, 2002, 3 (3) : 261 - 271
  • [8] Association of acquired von Willebrand syndrome with primary (AL) amyloidosis.
    Kos, CA
    Ward, JE
    Malek, K
    Sanchorawala, V
    Wright, DG
    O'Hara, C
    Connors, L
    Skinner, M
    Seldin, DC
    BLOOD, 2005, 106 (11) : 100B - 100B
  • [9] Daratumumab-based therapies in patients with AL amyloidosis.
    Abeykoon, Jithma P.
    Zanwar, Saurabh
    Kumar, Shaji
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Lacy, Martha
    Dingli, David
    Leung, Nelson
    Muchtar, Eli
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Buadi, Francis
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] A phase II trial of lenalidomide for patients with AL amyloidosis.
    Sanchorawala, V.
    Wright, D. G.
    Rosenzweig, M.
    Finn, K. T.
    Skinner, M.
    Seldin, D. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 428S - 428S
12345